Gene Expression

Discovery in Proprietary DNA Delivery System Announced

Published in Gene Therapy Weekly, September 7th, 2000

Supratek Pharma, Montreal, Quebec, Canada, announced at the American Chemical Society Annual Conference (ACS) that SP1017, its non-viral gene delivery system, significantly increases gene expression in muscle, dermal, and tumor tissues, and attracts dendritic cells to the site of transgene expression.

Dr. Valery Alakhov presented results at the ACS meeting held in Washington, DC, August 20-24, 2000, showing that SP1017 formulated with naked DNA coding for cancer-specific genes produced a strong anti-cancer effect due to the ability of the formulation to induce a strong cellular immune response against cancer implanted into animals. These new data suggest that SP1017...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (2000-09-07)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry